Treatment of the neutropenia of Felty syndrome.

Abstract:

:This review sets out to synthesize and critically evaluate the current reported data regarding therapeutic options for the neutropenia associated with Felty syndrome (Felty neutropenia). A MEDLINE search and bibliographies from recent reviews were used to identify trials and case reports that provided sufficient data to evaluate the effect of various interventions on both the neutropenia and the clinical course of patients with Felty syndrome. Data were obtained on baseline hematologic profiles, bone-marrow biopsies, and patient characteristics; length of follow-up; hematologic and clinical responses to the various interventions; and side-effect profiles. Treatment with hemopoietic growth factors or methotrexate can produce sustained hematologic and clinical responses with an acceptable side-effect profile. Splenectomy produces a long-term hematologic response in 80% of patients. Patients who do not respond hematologically have a higher incidence of non-fatal infections, but a significant minority (46%) do not experience any infections; the incidence of fatal infections is 12%, regardless of whether a hematologic response occurs. Of the patients who had infections prior to surgery, 55% did not experience further infections after splenectomy. Initial treatment of Felty neutropenia should consist of hemopoietic growth factors because of their rapid onset of action and relatively low incidence of side-effects. Splenectomy is a reasonable option if growth factors are ineffective and rapid amelioration of neutropenia is needed. Methotrexate offers a potentially promising alternative for the treatment of both the rheumatologic and the hematologic manifestations of Felty syndrome.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Rashba EJ,Rowe JM,Packman CH

doi

10.1016/s0268-960x(96)90024-7

subject

Has Abstract

pub_date

1996-09-01 00:00:00

pages

177-84

issue

3

eissn

0268-960X

issn

1532-1681

pii

S0268-960X(96)90024-7

journal_volume

10

pub_type

杂志文章,评审
  • Management of venous thromboembolism in athletes.

    abstract::Venous thromboembolism (VTE) is a common condition with high associated morbidity and mortality. Athletes have unique VTE risk factors compared with the general population, and may have a higher than anticipated risk of thrombosis. Anticoagulant treatment poses additional challenges in athletes, as these individuals u...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100780

    authors: Swan D,Carter-Brzezinski L,Thachil J

    更新日期:2020-11-15 00:00:00

  • Hemophagocytic syndromes--an update.

    abstract::Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome and not an independent disease. HLH represents the extreme end of a severe uncontrolled hyperinflammatory reaction that can occur in many underlying conditions. Genetic forms of HLHs are due to defects in transport, processing an...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.03.002

    authors: Janka GE,Lehmberg K

    更新日期:2014-07-01 00:00:00

  • Myelodysplasic syndromes: a comprehensive review.

    abstract::Myelodysplastic syndromes (MDS) are a set of oligoclonal disorders of hematopoietic stem cells characterized by ineffective hematopoiesis that manifest clinically as anemia, neutropenia, and/or thrombocytopenia of variable severity. The result often is transfusion-dependent anemia, an increased risk of infection or he...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.01.004

    authors: Catenacci DV,Schiller GJ

    更新日期:2005-11-01 00:00:00

  • Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.

    abstract::Platelets play a major role in primary hemostasis and thrombus formation. After vascular injury, platelets adhere to injured site and rapidly change their shape that switches the resting platelets to active state. Activated platelets aggregate and secrete biologically active intermediate substances that further potent...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.05.007

    authors: Kannan M,Ahmad F,Saxena R

    更新日期:2019-09-01 00:00:00

  • Back to base pairs: What is the genetic risk for red bloodcell alloimmunization?

    abstract::Red blood cell (RBC) alloimmunization is a serious complication of blood transfusions, challenging selection of compatible units for future transfusions. Genetic characteristics may be associated with the risk of RBC alloimmunization and may therefore serve to identify high-risk patients. The aim of this systematic re...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100794

    authors: Gerritsma JJ,Oomen I,Meinderts S,van der Schoot CE,Biemond BJ,van der Bom JG,Fijnvandraat K,SCORE consortium.

    更新日期:2021-01-05 00:00:00

  • B19 virus--a pathogenic human parvovirus.

    abstract::B19 virus is the first human virus to be shown to be a member of the parvovirus genus. This review is concerned with the diseases associated with B19 virus, their nature, pathogenesis and diagnosis. The virus was discovered by chance in blood donors but has been shown to be a common infection of childhood. Infection m...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90020-8

    authors: Pattison JR

    更新日期:1987-03-01 00:00:00

  • Resuscitation and transfusion principles for traumatic hemorrhagic shock.

    abstract::The transfusion approach to massive hemorrhage has continually evolved since it began in the early 1900s. It started with fresh whole blood and currently consists of virtually exclusive use of component and crystalloid therapy. Recent US military experience has reinvigorated the debate on what the most optimal transfu...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2009.07.003

    authors: Spinella PC,Holcomb JB

    更新日期:2009-11-01 00:00:00

  • Congenital platelet disorders.

    abstract::Congenital platelet disorders include thrombocytopathies and thrombocytopenias, which often occur in association. Thrombocytopathies constitute a model for exploring platelet physiology at the molecular level: adhesion, activation, release phenomena, aggregation. Further advances in understanding thrombocytopenias now...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90004-5

    authors: Bellucci S,Caen JP

    更新日期:1988-03-01 00:00:00

  • Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management.

    abstract::A working diagnosis of essential thrombocythemia (ET) is made in the presence of nonreactive thrombocytosis and after the exclusion of another chronic myeloid disorder that may mimic ET in its presentation. Clinically, ET is characterized by vasomotor symptoms, thrombohemorrhagic complications, recurrent fetal loss, a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0158

    authors: Tefferi A,Murphy S

    更新日期:2001-09-01 00:00:00

  • Optimizing platelet transfusion therapy.

    abstract::Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S0268-960X(03)00057-2

    authors: Heal JM,Blumberg N

    更新日期:2004-09-01 00:00:00

  • Disorders of oxidised haemoglobin.

    abstract::Methaemoglobinaemia arises from the production of non-functional haemoglobin containing oxidised Fe(3+) which results in reduced oxygen supply to the tissues and manifests as cyanosis in the patient. It can develop by three distinct mechanisms: genetic mutation resulting in the presence of abnormal haemoglobin, a defi...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2004.02.001

    authors: Percy MJ,McFerran NV,Lappin TR

    更新日期:2005-03-01 00:00:00

  • Human retroviruses.

    abstract::After many unsuccessful years of searching, the first pathogenic human retrovirus, the human T-cell leukaemia lymphoma virus (HTLV-I), was reported as recently as 1980 and since that time has been causally linked to the adult T-cell leukaemia lymphoma syndrome. A second HTLV (HTLV-II) isolated shortly afterwards is le...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90010-0

    authors: Thomson BJ,Dalgleish AG

    更新日期:1988-12-01 00:00:00

  • Disorders of neutrophil function.

    abstract::Major bacterial infections are most commonly associated with agranulocytosis or an abnormality of immunoglobulins or complement. Occasionally, repeated infections cannot be attributed to these relatively common causes. In such cases, a quantitative abnormality in neutrophil function should be sought. Complete evaluati...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(95)90024-1

    authors: Bogomolski-Yahalom V,Matzner Y

    更新日期:1995-09-01 00:00:00

  • Transfusion strategies for traumatic coagulopathy.

    abstract::Uncontrolled bleeding is the most common preventable cause of death for patients with severe injury. Coagulopathy inevitably accompanies severe bleeding, exacerbated by the ongoing blood loss and the treatments administered. There is debate about the underlying pathophysiological mechanisms of early traumatic coagulop...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2012.06.004

    authors: Curry NS,Davenport RA,Hunt BJ,Stanworth SJ

    更新日期:2012-09-01 00:00:00

  • MicroRNAs in hematological malignancies.

    abstract::MicroRNAs (miRNAs) have become one of the hottest topics in biology over recent years, but remarkably have only been formally recognized for just over 10 years. These endogenously produced short (19-24 nt) non-coding RNAs have introduced an entirely new paradigm in our understanding of gene control and it is now evide...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.04.002

    authors: Lawrie CH

    更新日期:2013-05-01 00:00:00

  • The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.

    abstract::Laboratory and clinical data relating to the use of 2'-deoxycoformycin in human disease are reviewed. Pentostatin is an inhibitor of adenosine deaminase, an enzyme that is important for purine metabolism, but more than one mechanism may be involved in its cytotoxic action. Early studies with dCF employed large doses a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90004-x

    authors: Spiers AS

    更新日期:1987-06-01 00:00:00

  • The unstable haemoglobins.

    abstract::The unstable haemoglobin haemolytic anaemias result from the presence in the red cell of a structurally abnormal haemoglobin variant. There are many mutations producing unstable haemoglobins; most are single amino acid replacements that affect a few key areas of the haemoglobin structure. A wide range of haemoglobin i...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(93)90002-l

    authors: Williamson D

    更新日期:1993-09-01 00:00:00

  • RhD haemolytic disease of the fetus and the newborn.

    abstract::When an RhD negative mother is exposed to the RhD positive red cells (usually as transplacental haemorrhage), she develops allo-anti-D which crosses the placenta and then results in the destruction of fetal red cells. Clinical manifestations of RhD haemolytic disease (HDN) range from asymptomatic mild anaemia to hydro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.1999.0123

    authors: Urbaniak SJ,Greiss MA

    更新日期:2000-03-01 00:00:00

  • The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.

    abstract::Most acute myeloid leukemia (AML) patients will be aged more than 65 years. Chronological aging is accompanied by decreasing stem cell and solid organ reserve as well as an increased incidence of medical comorbidity. For the older patient with AML, these patient-specific factors are compounded by an association with c...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.100639

    authors: Shallis RM,Boddu PC,Bewersdorf JP,Zeidan AM

    更新日期:2020-03-01 00:00:00

  • Alloimmune thrombocytopenia of the fetus and the newborn.

    abstract::Fetal/neonatal alloimmune thrombocytopenia results from a maternal alloimmunization against fetal platelet antigens. Care must be taken in making a correct diagnosis that eliminates other causes of thrombocytopenia that may occur during pregnancy. Biological diagnosis is normally made by platelet genotyping and search...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0187

    authors: Kaplan C

    更新日期:2002-03-01 00:00:00

  • Screening and genetic diagnosis of haemoglobin disorders.

    abstract::The inherited haemoglobinopathies are large group of disorders that include the thalassaemias and sickle cell disease. Carrier detection methods must be able to detect alpha-, beta- and deltabeta-thalassaemias, HPFH disorders and haemoglobin variants. Carrier diagnosis involves the accurate measurement of MCH, MCV, Hb...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(02)00061-9

    authors: Old JM

    更新日期:2003-03-01 00:00:00

  • Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

    abstract::ABVD continues to be the standard of care for patients with advanced stage Hodgkin Lymphoma (HL) although escalated BEACOPP has improved survival in one randomized controlled trial (RCT). More intensive regimens have higher rates of acute and late toxicities and this poses significant issues for patients. Consolidatio...

    journal_title:Blood reviews

    pub_type: 杂志文章,随机对照试验,评审

    doi:10.1016/j.blre.2012.04.001

    authors: Uhm J,Kuruvilla J

    更新日期:2012-07-01 00:00:00

  • Thrombopoietic agents.

    abstract::Thrombopoietin (TPO) is the key cytokine involved in thrombopoiesis, and is the endogenous ligand for the thrombopoietin receptor that is expressed on the surface of platelets, megakaryocytes, and megakaryocytic precursors. First-generation thrombopoietic agents were recombinant forms of human TPO, and their developme...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2010.04.002

    authors: Stasi R,Bosworth J,Rhodes E,Shannon MS,Willis F,Gordon-Smith EC

    更新日期:2010-07-01 00:00:00

  • Pathophysiology of aplastic anaemia.

    abstract::It is the conventional opinion that acquired aplastic anaemia is a heterogenous disease including basically different conditions, such as idiopathic or virus induced pancytopenia, toxic-allergic marrow damage or autoimmunity. Here, an alternative concept is proposed, according to which aplastic anaemia is one disease,...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(90)90032-n

    authors: Nissen-Druey C

    更新日期:1990-06-01 00:00:00

  • Enzyme therapy for Gaucher disease: the first 5 years.

    abstract::Gaucher disease was first described by Philippe Gaucher in his 1882 medical thesis. Gaucher's original concept was of an unusual epithelioma of the spleen. By the early 1900s, Mandelbaum recognized the systemic nature of the disease. Several children with Gaucher disease were described at the turn of the century, but ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(98)90023-6

    authors: Grabowski GA,Leslie N,Wenstrup R

    更新日期:1998-06-01 00:00:00

  • Cerebral venous thrombosis-a primer for the haematologist.

    abstract::Cerebral venous thrombosis (CVT) is a condition that can affect all age groups and can often be difficult to diagnose and treat. The difficulties in diagnosis are mainly due to the non-specific presenting features of CVT, which can range from isolated headache and visual or auditory problems, to serious symptoms such ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.09.006

    authors: Thorell SE,Parry-Jones AR,Punter M,Hurford R,Thachil J

    更新日期:2015-01-01 00:00:00

  • Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices.

    abstract::Chronic lymphocytic leukemia (CLL) is a disease of older patients and median age at diagnosis is 72 years. This older group is under-represented in clinical trials, (median age 58-62 years). Here we review background data on incidence, survival, definitions of older age, fitness criteria, frailty and co-morbidities. I...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2011.09.002

    authors: Tadmor T,Polliack A

    更新日期:2012-01-01 00:00:00

  • Autophagy: A necessary event during erythropoiesis.

    abstract::Autophagy is a well-known cellular process involved in many physiological and pathological processes. During erythropoiesis, autophagy plays an important role participating in the clearance of unnecessary organelles such as ribosomes and mitochondria (mitophagy) allowing the correct formation of mature red blood cells...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.04.001

    authors: Grosso R,Fader CM,Colombo MI

    更新日期:2017-09-01 00:00:00

  • Interleukin 2 and its receptor: structure, function and therapeutic potential.

    abstract::In this review, salient molecular, biochemical and functional features of human interleukin 2 (IL-2), its membrane receptor, and its clinical relevance are outlined. We also describe experimental systems, where observed biological or pharmacological effects of IL-2 could be applied to corresponding clinical situations...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90027-0

    authors: Malkovský M,Sondel PM

    更新日期:1987-12-01 00:00:00

  • What can we learn from ineffective erythropoiesis in thalassemia?

    abstract::Erythropoiesis is a dynamic process regulated at multiple levels to balance proliferation, differentiation and survival of erythroid progenitors. Ineffective erythropoiesis is a key feature of various diseases, including β-thalassemia. The pathogenic mechanisms leading to ineffective erythropoiesis are complex and sti...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.10.001

    authors: Oikonomidou PR,Rivella S

    更新日期:2018-03-01 00:00:00